Lack of reversion in triclabendazole-resistant Fasciola hepatica.
Borgsteede
F H M
FH
Animal Sciences Group, WUR, Division of Infectious Diseases, PO Box 65, NL-8200 AB, Lelystad, The Netherlands.
Moll
L
L
Vellema
P
P
Gaasenbeek
C P H
CP
D000818:Animals; D000871:Anthelmintics / Q000494:pharmacology / Q000627:therapeutic use*; D000909:Antibodies, Helminth / Q000097:blood; D001562:Benzimidazoles / Q000494:pharmacology / Q000627:therapeutic use*; D004351:Drug Resistance; D005210:Fasciola hepatica / Q000187:drug effects*; D005211:Fascioliasis / Q000188:drug therapy / Q000662:veterinary*; D005243:Feces / Q000469:parasitology; D005260:Female; D008297:Male; D009426:Netherlands; D010270:Parasite Egg Count / Q000662:veterinary; D021261:Parasitic Sensitivity Tests / Q000662:veterinary; D012756:Sheep; D012757:Sheep Diseases / Q000188:drug therapy*; D016896:Treatment Outcome; D000077682:Triclabendazole
D000871:Anthelmintics; D000909:Antibodies, Helminth; D001562:Benzimidazoles; D000077682:Triclabendazole